LU WEIBING 4

4 · SKYSTAR BIO-PHARMACEUTICAL CO · Filed May 8, 2012

Insider Transaction Report

Form 4
Period: 2012-05-04
LU WEIBING
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Common Stock

    2012-05-04$2.58/sh+233,333$601,9991,172,459 total
Footnotes (2)
  • [F1]Stock grant pursuant to the Company's 2010 Stock Incentive Plan as approved by the Board of Directors.
  • [F2]Includes shares of common share of the Company which are held by Upform Group Limited.

Documents

1 file
  • 4
    v312162_4.xmlPrimary

    OWNERSHIP DOCUMENT